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THE ROLE OF OXYTOCIN IN MODULATING NEURAL OSCILLATIONS IN NULLIPAROUS 
WOMEN. Xiaoyue Mona Guo, Helena J.V. Rutherford, Linda C. Mayes. Child Study Center, 
Yale University, School of Medicine, New Haven, CT. 
The hormone oxytocin (OT) has been implicated in social cognition and behavior as well 
as in modulating important affiliative relationships such as parenting; meanwhile, 
intranasal OT administration is gaining popularity as a means to modulate neural 
activity in brain regions during experimental tasks. However, the neural mechanisms 
underscoring the changes associated with OT administration have yet to be fully 
elucidated. Using electroencephalography (EEG), this thesis project aims to further our 
understanding of how OT affects brain activity and response to infant cues. In a double-
blind placebo controlled design, OT’s effect on resting-state neural oscillations and 
event-related potentials (ERPs) to face stimuli were examined in a cohort of nulliparous 
women of childbearing age. Specifically, we examined the effects of intranasal OT on 
delta, beta, and delta-beta coupling during the resting state, and the amplitudes of the 
ERP components N170, P300, and the Late Positive Potential (LPP) to infant and adult 
faces. Prior work has suggested that cross-frequency coupling may be a useful way to 
study cognitive processing, whereas the N170, P300 and LPP are all components 
involved in the processing of facial and emotional stimuli. We found that OT, relative to 
placebo, decreased delta-beta coupling across multiple brain regions; ERP data showed 
that OT administration led to an increased amplitude of the P300 component to infant 
faces compared with adult faces. Taken together, these findings demonstrate that OT 
administration may lead nulliparous women to allocate greater attentional resources to 
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Over the past decade, oxytocin (OT) has made news headlines from “OT makes people 
more trusting” to “Hormone OT jump-starts maternal behavior” [Data Source: Google 
Trends (www.google.com/trends)]. This so-called “love hormone” has gained attention 
in the research field for both its seeming influence on an increasing myriad of human 
behaviors and its potential for use in clinical populations. However, despite the four-
fold increase in the number of publications over the past decade on OT and social 
cognition or behavior [1], there continue to be an absence of knowledge about OT’s 
basic neurophysiological effects. What’s more, notably lacking are studies on female 
participants due to the difficulties of controlling for hormonal interactions. 
This thesis will provide a brief overview of the roles OT may play in social contexts and 
of how electroencephalography (EEG) can help inform this body of research, 
particularly for women. The studies described will investigate how OT administration 
affects brain responses in a cohort of healthy nulliparous women as measured by EEG 
both at rest and in response to social and nonsocial cues.  
Physiologic Roles of Oxytocin 
Derived from the Greek word oxutokia (oxus or ‘sharp’ + tokos or ‘childbirth’ = ‘sudden 
delivery’), OT is a neuropeptide produced by the hypothalamus that acts as both a 
peripheral hormone and a central neurotransmitter. OT belongs to an ancient class of 
molecules known as nonapeptides, which are found in virtually every vertebrate 
phylum, with a lineage that can be traced through invertebrates. Despite the different 




in the brain and gonads (with OT shown to be synthesized further in somatic organs 
such as the heart, thymus and gastrointestinal tract [2]), are influenced by gonadal 
steroids, and are important for social behavior [3]. Much of what we understand of 
oxytocin’s physiologic activity are from animal models, and very early studies suggested 
the importance of OT and the OT receptor in triggering critical aspects of pair bond 
formation and maternal behavior in rodents [3]–[5] which have since been replicated in 
higher-order mammals and primates [5], [6]. 
In humans, OT has a few well-described natural effects: in women, OT induces uterine 
contractions during parturition and is involved in milk release during breastfeeding.  
For both men and women, OT is released during sexual stimulation and orgasm, may 
reduce urine volume and induce natiuresis through co-activation of vasopressin 
receptors, and is involved in the modulation and regulation of the hypothalamic-
pituitary-adrenal (HPA) axis [3]. On a cellular level, oxytocinergic neurons project to 
limbic, mid-, and hindbrain structures including the hippocampus and amygdala; they 
also have indirect effects on the activity of higher cortical functioning and the synaptic 
transmission of other neurotransmitters, including serotonin [7]–[9].  
Importantly, there is a greater understanding of how the OT system is endogenously 
mediated by changes in OT receptors, whether via dynamic regulation in density and 
location by hormones like estrogen, or genetic and epigenetic differences between 
individuals. Pregnancy is a leading example, when elevated estrogen levels prime the 
maternal brain for increased synthesis of both OT and OT receptors, and lead to marked 
increases in OT receptor density in the uterus, mammary myoepithelium, and 




gene have been suggested to affect the efficiency of OT signaling in individuals [11], 
particularly with regards to caregiving behaviors such as parental touch [12] or 
response to infant faces [13]. However, a meta-analysis found that the direct 
social/behavioral impact of these genetic variances are inconsistent and small in 
magnitude [14], with increasing research now focusing on epigenetic modifications of 
the receptor gene via early childhood experiences [15], [16]. 
Influence of Intranasal Oxytocin on Social Behavior 
Given these traditional associations of OT with affiliative behaviors, it is not surprising 
that OT has been broadly mapped onto human neurobiology with its actions translated 
towards affecting important human relationships (see reviews [10], [17]). To assess 
experimentally the central actions of OT in humans, intranasal administration has 
gained wide support and popularity of use. While minimal pharmacokinetic 
information exists on intranasal OT, a number of studies evidenced elevated levels of 
salivary OT for up to seven hours post administration [18]–[20]. More importantly, the 
nasal route circumvents the blood-brain barrier and leads to replicable behavioral and 
functional changes [15], [21]. However, it is worth noting that this methodology is not 
without its criticisms; taking into account the prevalence of somatic OT receptors and 
that a modest percentage of intranasal OT reaches the cerebral spinal fluid compared 
to the peripheral circulation, care needs to be taken in interpreting behavioral results 
as centrally versus peripherally driven [22]. 
Increasingly, OT has been associated with various aspects of positive human sociability 
including supporting partner communication and interactions [23], [24], improving 




building [27]–[29]. In healthy populations, these results translate to a promise of stress 
reduction and anxiolysis [30], [31] as well as enhanced prosocial behavior [11]. 
Coupled with clinical research showing that plasma levels of OT are inversely related 
to depressive [32] and psychotic [33] symptomology, therapeutic considerations have 
risen for OT use in a host of patient intervention protocols from autism and 
schizophrenia to post-traumatic stress disorder and depression [34]–[37]. The crux of 
these treatment effects may lie in OT’s anxiolytic properties, as it decreases an 
individual’s aversion to negative internal or external stimuli [15]. 
However, despite excitement about OT’s potential pharmacologic role, little is known 
about the neural basis underlying these effects, and inconsistencies abound between 
various studies in dosages used (from 2 IU to 320 IU) and the durations to wait after 
spray administration before measuring changes in the dependent variables [10], [15], 
[38]. Moreover, there is burgeoning evidence that OT also has negative influences such 
as increasing feelings of exclusion [39], and that the behavioral presentation depends 
on the individual. The end-effect of OT appears to be moderated by environmental 
contexts, personal characteristics, and early childhood experiences. Specifically, OT 
plays a stronger role when considering in-group situations, and in participants with 
lower attachment anxiety and supportive parenting backgrounds [15], [40].  
Differential Oxytocin Effects on Women 
Oxytocin and the Mother 
Encompassing all the above described affiliative behaviors of trust and empathy is the 




that of reproduction and parturition physiology was the stimulation of a nurturing, 
maternal phenotype in virgin rats that were centrally administered with OT [41]. 
Multiple human and animal studies since have supported this observation and 
implicated OT in having a key role in the formation and development of the infant-
parent bond [6], [42]. For example, affectionate and stimulatory parenting behaviors 
are correlated with OT levels in new mothers and fathers, respectively [10], and 
securely attached mothers have a stronger OT response following a play interaction 
with their child as compared to insecurely attached mothers [43]. Moreover, a steady 
rise in OT levels from the first through third trimester in a pregnant woman is 
correlated with higher self-reported bonding scores to her unborn infant [44]. There 
also appears to be a genetic basis underlying the parental OT pathway, with low-risk OT 
receptor alleles corresponding with more sensitive parental care [12], and stronger 
preference for infant faces [13], [45].  
One way to experimentally study parenting is through examining and comparing the 
response to infant versus non-infant cues. This predilection for infant cues (faces and 
cries) that seems to instinctively trigger feelings of protection and caretaking may arise 
from an innate positive affect towards the “baby schema,” a collection of infantile 
characteristics like big eyes and round features [46]. Multiple studies show individuals 
having greater responses in brain regions associated with face processing, attention, 
and reward when viewing infant versus adult faces; the use of images or sounds from a 
parent’s own infant further enhances these responses (see review [47]). With its 
association with affiliative behavior, intranasal OT administration also unsurprisingly 




More recent work suggests that a number of individual differences, including substance 
use [49] and depression [50] may also affect the neural response to infant cues. As 
stress and addiction both impact prefrontal cortical function [51], [52] these states 
may have detrimental effects on executive function as it relates to parenting behavior 
[53]. Evidence further shows OT to have a bidirectional relationship with HPA activity 
[54] and drug exposure [55]. In rodents, chronic OT administration leads to a 
reduction of the acute stress response [56]; OT has also been shown to be released by 
the heart and vasculature, suggesting a role in the modulation of cardiac activity and 
vascular tone [57], [58]. Accordingly, in mothers 2 – 6 months postpartum, the amount 
of plasma OT following stress induction was related to lower cardiac and vascular 
reactivity and increased levels of norepinephrine [59]. This attenuation of the HPA axis 
by OT is further observed with lactating mothers, where a rise in OT following 
breastfeeding is inversely related to ACTH and cortisol levels, and the act of 
breastfeeding can decrease HPA responses to a stress exposure [44]. These studies 
suggest potential benefits of OT in modulating the physiological stress responses that 
are critical factors in parenting; they further suggest that OT may have a wider 
regulatory function than previously thought.  
More broadly, global gray matter volume has been shown to significantly increase in 
mothers from 2 – 4 weeks to 3 – 4 months postpartum [60], supporting a notion that 
cortical reorganization over the postpartum period serves to facilitate parenting 
behavior and the orientation of attention and perception towards the infant. The exact 
neurological basis of parenting, however, is still unknown. An area of accumulating 
evidence is the idea that that reward neural circuits in mothers are recruited when 




studies have shown the importance of increasing orbitofrontal cortex activity in various 
aspects of parenting, including when listening to infant cries versus white noise [62], 
[63], viewing pictures of own infant faces versus unknown infant faces [64], perceiving 
infant faces as compared to adult faces [65], and distinguishing maternal from 
romantic attachment [66]. OT administration has been shown to directly affect neural 
activation of similar regions, with a recent meta-analysis of fMRI studies on mother-
infant interactions finding greater activation of the left insula but decreased activation 
of the dorsomedial frontal cortex in the maternal brain [67].  
Oxytocin in Nulliparous Women 
Despite rich research on the maternal-infant relationship, it is difficult to understand 
the changes that occur in a woman’s affiliative processing abilities throughout the 
course of pregnancy and into early and late-postpartum periods. This is made even 
more complicated by further differences in the neural response to infant cues while 
comparing parents to non-parents [68], suggesting a unique parental neurologic state 
that could be in part modulated by OT. Multiple studies describe how intranasal OT 
administration modifies a nulliparous woman’s neural and behavioral responses to 
infant cues to being more similar to those of a postpartum woman. For instance, 
nulliparous participants given OT have increased empathy and decreased negative 
affect towards a crying infant, and report higher arousal by photos of infants [69]–[71].  
The OT literature has burgeoning data supporting the existence of underlying sexual 
dimorphism modifying OT’s physiologic effects and the importance of appreciating 
these sex-dependent effects particularly for translational research [72].  Indeed, a 




producing areas of the brain and sex-specific behaviors. By optogenetically turning on a 
group of hypothalamic neurons, the researchers were able to increase a virgin female 
rats’ pup retrieval behavior and circulating OT levels in rats of both sexes, providing 
new causative data on gender differences in social or reproductive behaviors [73]. In 
human women compared to men, OT is associated with almost opposite neural imaging 
findings particularly in the temporal lobes and subcortical areas such the amygdala 
[38], [74]. The neuropeptide has also been shown to reduce self-reported anxiety 
measures in women who use emotion-oriented coping mechanisms but not men [75], 
and generally leads to more “tend and befriend” traits instead of the “fight and flight” 
responses of the male participants [76], [77]. Similarly, there is some indication that OT 
makes a male’s neural responses, especially older men’s, more similar to that of females 
[78], [79].  
Despite gender being a well-explored moderator of OT effects on social cognition, a 
significant limitation to our understanding of maternal-infant relationships is a scarcity 
of data using non-maternal female populations. This bias is evident in the 44 
publications using intranasal OT prior to 2010, where 32 used an all-male participant 
pool and only one used an all-female group [17]. In order to avoid potential interactions 
and confounding by hormonal variances, researchers often do not recruit female 
participants, and thus our foundation of OT-related knowledge has predominantly been 
anchored on male-oriented studies. For the studies that do use females and males, some 
show a lack of gender differences (i.e., [80]–[82]), possibly due to differences in study 
design and inclusion/exclusion criteria of the participants (including but not limited to 




A well-controlled, mechanistic understanding of OT’s effects on the nulliparous female 
brain thus still requires study. This thesis employs a female-only sample given the 
limited knowledge of OT effects on neural activity in this group, to help augment our 
sex-specific appreciation of OT modulation. 
Assessing Neural Responses to Oxytocin Using Electrophysiology 
Given the sometimes conflicting and inconsistent results of intranasal OT research, 
there is growing interest towards exploring its effects using behavioral and functional 
neuroimaging [83]. The majority of these intranasal OT studies have employed 
functional magnetic resonance imaging (fMRI), a methodology relying on changes in 
blood oxygenation to determine brain activity [38]. However, electroencephalography 
(EEG) provides a valuable alternative to imaging data by enabling a direct index of 
neuronal activity through measuring post-synaptic potentials of cortical pyramidal 
neurons [84]. The few studies using EEG have mostly shown that OT administration 
mainly alters cortical activity during social tasks, specifically, and that these neural 
effects correspond with performance on these tasks [38]. Through complementing the 
spatial resolution of fMRI findings with the temporal resolution of EEG studies, a more 
comprehensive picture of the neurophysiology behind OT administration on human 
cognitive and social behavior can be formed. 
Delta-Beta Coupling 
In EEG, tightly coupled neural correlates can be measured as oscillations of varying 
frequency: slow waves (i.e., delta, theta) are thought to reflect subcortical emotion and 




reflect more cortical cognitive control processes [85]. Prior research has found no 
changes in the neural activity of individual frequency bands with OT administration 
when EEG was recorded at rest without social stimuli or tasks [38], [86]. As such, 
interest has increasingly veered away from the study of individual frequency bands to 
focus on cross-frequency coupling, measured as correlations between the amplitudes of 
slow- and fast-wave oscillations, to understand complex brain interactions more fully. 
Indeed, this method may be more sensitive to the complexities of OT effects [87].  
In particular, amplitude-amplitude coupling between delta and beta activity may 
represent a synchronization or interface between emotional or motivational systems 
and higher-order cognition, given the likely subcortical and cortical generators of these 
oscillations, respectively [85]. Support for this approach can be garnered from studies 
examining delta-beta correlations when the interplay of affect and cognition may be 
compromised, particularly in relation to increased levels of stress and anxiety. For 
example, there is a positive association between the strength of delta-beta coupling and 
basal cortisol levels [88]; intranasal administration of cortisol also increases this 
correlation, an effect that was amplified in participants with higher levels of behavioral 
inhibition [89]. Furthermore, delta-beta coupling is increased in more anxious 
individuals and decreased after the treatment of anxiety [90]. Consequently, given the 
previously described properties of OT in decreasing stress and anxiety, OT 
administration may modulate cross-frequency coupling on EEG despite not affecting the 
activity of individual frequency bands.  
In the first portion of the current study, EEG served as a viable tool for evaluating and 




in the absence of any social or behavioral task. Through observing OT effect on the 
amplitudes of delta, beta, and delta-beta coupling at rest, we can directly examine the 
role of OT at the neural interface of emotional or motivational systems and cognition 
[85]. Given the aforementioned relationship of delta-beta coupling with anxiety, it was 
hypothesized that administration of intranasal OT, relative to placebo, would decrease 
delta-beta coupling, consistent with OT’s association with decreasing stress and anxiety. 
As previous research has not shown changes in delta and beta oscillations following 
hormonal manipulations, it was anticipated that these individual frequency bands 
would similarly be unaffected by OT administration. 
Event-Related Potentials to Infant Faces: N170, P300, LPP 
Evoked or event-related potentials (ERPs) are another way of observing the brain’s 
electrical potentials as elicited by specific sensory events. Whereas the rhythmic 
oscillations of EEG show a more general state of activity, ERPs enable the analysis of 
the synchronized processes of a population of neurons underlying perceptual, 
attentional, and cognitive responses in a time-locked manner.  
Characteristic ERP waveforms are associated with different visual stimuli; faces are 
particularly prominent in the literature as eliciting a stereotypical response. The N170, 
a negative ERP component 170ms after the presentation of the stimulus, is an early 
marker of the structural encoding of human faces [91], [92]. Correlating with fMRI, the 
N170 is most prominent over brain areas implicated in face processing (e.g.,the 
fusiform gyrus) [34]. Infant faces have been shown to differentially affect this 
component compared to adult faces in parents and non-parents alike, while being 




response is affected by individual differences in sensitivity to infant cues such as 
parental status and mood [50], [94]. It has also been shown to be modulated by the 
infant’s emotional expression (particularly of distress), although the literature is mixed 
regarding how the amplitude of the N170 changes in response to the cue versus other 
parental characteristics like depressive symptomology [95]. 
The P300 or P3 positivity component is another well-described ERP configuration 
triggered by detection of or attention to an improbable, ‘oddball’ stimulus [92]. 
Compared with the immediacy of components like that N170 that correspond with the 
initial perception of a stimulus, the P300 is associated with a later stage of cognitive 
processing that requires more long-term memory and recognition [96]. Overall, it 
appears to reflect attention allocation towards motivationally salient and task-relevant 
stimuli, as the P300 amplitude is directly related to subjective perceptions of the 
probability of and attentional engagement to the stimulus [96], [97]. Crucially, P300 
activity has been evidenced to be sensitive to prosocial behavior [98], and emotional 
stimuli in particular leads to a sustained P300 dubbed the late positive potential (LPP). 
More specifically, the LPP reflects a conscious allocation of attention to, and presumed 
continuous processing of, motivationally significant emotional stimuli [97]. 
Both the P300 and LPP have been explored in the context of the presumed relative 
importance of processing infant cues [95]. The P300 is greater in amplitude when 
mothers are tested with cues of their own versus an unknown infant [93], [99] and 
greater with distressed infant faces [68]. For the LPP, mothers who were more 
accurate in face recognition tasks to negative infant expressions had larger amplitudes 




emotional infant faces [94]. Similar to the N170, characteristics of the P300 and LPP 
also appear to be modulated by individual differences, such as the desirability or 
preference for the stimuli, parental status, anxiety, and early childhood experiences 
[93], [97], [100], [101].  
Taken together, the N170, P300, and LPP embody different processing modalities of 
infant cues, with the former representing earlier, more automatic perception and the 
latter representing higher-order cognition. Newer evidence suggests that face 
processing may be influenced by the affective significance of the stimuli and therefore 
interact with emotion or reward systems [102]; a few imaging studies show an 
interaction between the fusiform gyrus and the amygdala or orbitofrontal cortex 
during face viewing [65], [102]. Although dopamine and norepinephrine have been 
implicated in the manifestation of the P300 and LPP [97], there are a few studies 
exploring neurohormonal involvement with other ERP responses. Oxytocin, with its 
reported roles in attention allocation for faces and emotional events, may be an 
integral molecular modulator of these neural responses particularly with regard to 
affiliative stimuli.  
In the second part of this thesis, we performed an ERP analysis on the N170, P300, and 
LPP components, employing neutral and distressed infant and adult faces with non-
social stimuli (houses) as a control. Given OT’s aforementioned properties in social 
behavior, it was expected that OT administration would increase sensitivity to faces 
compared with houses, and emotional compared with neutral faces. A prior study 
showed that mothers with certain alleles of the OT receptor gene have earlier latencies 




response to infant faces [13]. Other studies showed that elevated P300 amplitudes 
were directly associated with OT levels in foster parents viewing photos of their child 
[103], while OT administration led to larger LPP amplitudes with emotional faces 
[100]. As such, it was hypothesized that OT administration would increase both the 
early N170 component and the later P300 and LPP amplitudes in our cohort of 
nulliparous women. Specifically, we hypothesize that OT will further increase the 
amplitudes of the N170 and P300 for infant compared with adult faces, and LPP for 




STATEMENT OF PURPOSE 
Aim:  
The specific aim of this thesis is to determine how OT affects (1) resting-state neural 
oscillations and (2) event-related potentials in response to social stimuli in healthy, 
nulliparous women. 
Hypotheses: 
Intranasal OT administration will: 
(1) Decrease delta-beta coupling in participants at rest without affecting the activity 
of the individual delta and beta frequency bands 
(2) Increase sensitivity of the participants to social stimuli as compared to placebo, 
measured as increased amplitudes of the: 
a. N170 to infant faces compared with adult faces 
b. P300 to infant faces compared with adult faces 






Note: Helena Rutherford (HR) and Linda Mayes (LM) designed the experiments and 
trained me (XMG), Nathan Hayes (NH), and Kelsey Graber (KG) on all protocols. NH and 
KG performed the telephone eligibility screening. XMG, NH, and KG conducted the visits 
and ran the participants through the face-viewing tasks. XMG and HJVR analyzed the 
data and HJVR performed the statistical analyses. 
Participants 
Twenty-six healthy, nulliparous women from the Yale University and New Haven 
community were recruited using flyers for two study visits scheduled four weeks apart 
to facilitate continuity in menstrual cycle phase. Eligibility was assessed by telephone 
screening and exclusion criteria included pregnancy, use of any hormonal birth control, 
clinically significant medical or psychiatric illnesses, and use of psychotropic 
medications. A full list of inclusion/exclusion criteria are listed in Table 1.  
All participants gave informed consent during the first visit and were compensated $80 
for each visit ($160 total). Two participants did not return for a second visit and the 
data from one participant could not be analyzed due to excessive artifacts. Therefore, 
the final sample consisted of 23 nulliparous women (22 single, 1 married), aged 18 – 31 
years (M=23.3; SD=3.3). Using self-reported menstrual data, half of the participants 
were in the luteal phase of their menstrual cycle. All were high school graduates 
(M=16.7 years of education; SD=2.0). Self-identified ethnicity was: Caucasian/White 
(n=14), Asian-American/Asian (n=5), African-American/Black (n=1), Hispanic/Latina 




reported current marijuana use; no participants had present or past alcohol or 
substance abuse as gauged by the Addiction Severity Index Lite CF [104] interview. 
Table 1. Inclusion and exclusion criteria used for telephone screening of participants 
Inclusion Criteria Exclusion Criteria 
• Adults ages 18-64 
• Good medical health 
• Ability to understand 
and speak English 
• Nulliparity 
 
• Medical Illnesses:  
o Moderate or severe acute or chronic medical illnesses 
(e.g. cardiac disease, diabetes, epilepsy, influenza). 
• Cardiovascular risk factors: 
o History of hypertension with baseline blood pressure 
above 140 mm Hg (systolic) over 90 mm Hg (diastolic) 
o Any history of syncope and/or baseline blood pressure 
below 100 mm Hg (systolic) 
• CNS disease:  
o Known history of brain abnormalities (e.g., 
neoplasms, subarachnoid cysts), cerebrovascular 
disease, infectious disease (e.g., abscess), or other 
central nervous system disease 
o History of head trauma that resulted in a persistent 
neurologic deficit, or loss of consciousness > 3 
minutes 
• Medication status:  
o The use of contraceptive hormones 
o The use of any psychotropic medications excluding 
those individuals on stable doses of a neuroleptic 
and/or an antidepressant medication for at least the 
past 6 weeks 
Procedure 
All procedures were approved by Yale School of Medicine Human Investigation 
Committee (HIC: 1309012677) and registered under clinicaltrials.gov (Identifier: 
NCT02238379). Both visits occurred between 1200h and 1500h in order to minimize 
diurnal variations in hormone levels, with attempts to schedule the participant at the 
same time on both days [105]–[107]. Participants refrained from exercising and alcohol 
use for 24 hours, caffeine intake for 12 hours, and smoking and eating for two hours 
before each visit. Upon arrival, participants had their blood pressures measured and 




participants were pregnant or evidenced recent substance use in their urine toxicology 
or breathalyzer tests. 
Given the intranasal route of the spray administration, participants filled out a nasal 
questionnaire (www.nwentallergy.com) to document the presence and severity of 
symptoms such as nasal congestion and itching. All participants had minimal symptoms, 
with total scores of less than four (out of 15) during their first visit and with one 
participant scoring six during the second visit due to a recovering upper respiratory 
illness. Moreover, participants completed various personality questionnaires including 
the State-Trait Anxiety Inventory (STAI) [108], the Beck Depression Inventory-II (BDI) 
[109], the Perceived Stress Scale (PSS) [110], and the Parental Bonding Instrument 
(PBI) [111] during each visit (Table 2). The only statistical difference found was for 
State Anxiety, with participants scoring lower on the visits where they received OT 
compared to placebo sprays (M=30.8, SD=7.2 versus M=34.7, SD=10.9; p=0.03). 
However, both scores lay well below the cutoff for clinically significant anxiety 
symptoms, and Trait Anxiety was not statistically different between conditions. Finally, 
routine safety monitoring with blood pressure, heart rate, and temperature 
measurements was conducted throughout the visit. 
In this double-blind, within-subject crossover design, participants received, at random 
and counterbalanced, either OT (United States Pharmacopeia) or a placebo delivered by 
nasal spray. Both substances were in identical bottles and prepared by the 
Investigational Pharmacy at Yale-New Haven Hospital. After priming the bottle, 
participants administered four puffs of spray, alternating nostrils with 15 seconds 




because of there being no adverse behavioral and neurobiological effects in previously 
reported intranasal administrations [112]. The placebo spray contained all ingredients 
except the active OT. In post-experiment interviews, participants were unable to 
identify better than chance whether they received the OT (n=4 guessed correctly) or 
placebo (n=5 guessed correctly) spray. After a 45 minute rest period, participants first 
completed the ERP Experiment lasting 25 minutes, followed by the EEG Experiment 
(described below). Each visit lasted approximately two hours, with both visits having 
the same procedural flow.  
Table 2. Mean scores and standard deviation (SD) for questionnaires completed by participants on 
separate visits prior to nasal spray delivery. Paired two-tailed t-tests were used to calculate p-value 
for comparison between conditions if appropriate. 
Questionnaire Placebo Oxytocin p-value 
Beck Depression Inventory a 4.3 (SD=5.9) 4.1 (SD=6.2) 0.93 
Perceived Stress Scale b 17.7 (SD=7.3)‡ 17.0 (SD=8.0) 0.31 
State-Trait Anxiety Inventory c    
State Anxiety 34.7 (SD=10.9) 30.8 (SD=7.2) 0.03 
Trait Anxiety 30.3 (SD=7.6) 29.9 (SD=7.9) 0.79 
Parental Bonding Instrument d    
Maternal Care 29.6 (SD=6.8)  
Paternal Care† 27.7 (SD=8.8)  
Maternal Protection 13.2 (SD=7.9)  
Paternal Protection† 11.1 (SD=8.8)  
†1 participant did not report paternal care or protection scores  
‡1 participant had incomplete questionnaire  
a Scores <13 indicate minimal depression 
b Scores of 16-20 indicate slightly higher than average stress 
c Scores >40 suggest clinically significant anxiety symptoms 
d Optimal parenting is defined as high care (maternal>27, paternal>24) and low protection 





All data were collected in a sound-attenuated room under low ambient light conditions. 
A 128 Hydrocel Ag/AgCl electrode sensor net (Electrical Geodesics, Inc.; Tucker, 1993) 
was soaked in a warm potassium chloride solution and fitted according to manufacturer 
specifications evenly and symmetrically across the participant’s scalp from nasion to 
inion and from the left to right ear. Continuous EEG was recorded using Net Station 
4.2.1 with a sampling rate of 250 Hz and high impedance amplifiers (Net Amps 200, 
0.1Hz high pass, 100Hz low pass). Electrodes were referenced to the vertex (Cz) during 
EEG recording and impedances were kept below 40 kΩ.  
EEG Experiment 
After the ERP Experiment and approximately 70 minutes after intranasal 
administration of OT or placebo sprays, participants completed a resting state eyes-
open eyes-closed EEG task. This task consisted of a continuous series of six one-minute 
recording periods as participants sat quietly in alternating eyes-open (EO) and eyes-
closed (EC) conditions (i.e. OCOCOC).  
ERP Experiment 
Participants were asked to sit quietly for 45 minutes after administration of either the 
OT or placebo spray with blood pressure and heart rate monitored throughout.  The 
experimental task began with nine practice trials containing stimuli not included in the 
experiment (photographs of farmyard animals) following the same protocol as the 




between 400 – 600ms), stimulus presentation (1000ms), and a blank screen (1000ms). 
All stimuli were randomly selected and presented on a uniform black background. 
Experimental stimuli were grayscale photographs of 12 unique infant faces, 12 unique 
adult faces, and 24 unique houses. With identity held constant, half (6) of the faces in 
each group for both infants and adults showed distressed expressions while the other 
half (6) showed neutral expressions. Pre-tests were conducted using all the face stimuli 
to confirm their emotional content. 
Each participant completed four blocks of 108 experimental trials. Within each block, 
48 face stimuli (50% of the faces were infants; 50% of the expressions were distressed) 
and 48 house stimuli were presented. In order to assure participant attention, an 
additional 12 catch trials requiring a key press response were included in each 
experimental block, but were not included in the final analysis. In total there were 192 
house trials and 192 face trials (48 Adult Distress, 48 Adult Neutral, 48 Infant Distress, 
and 48 Infant Neutral). The face-viewing experiment took approximately 25 minutes to 
complete. 
Data Analysis  
All analyses were performed blind the spray condition of each participant. Net Station 
4.5 was used to pre-process all raw EEG data and prepare the data for statistical 
analysis. Secondary analyses of any interactions between the self-report questionnaires 
(i.e. STAI, PSS, BDI, PBI) and EEG data will be conducted in a follow-up study and are not 






To analyze EEG data during the resting conditions, the data was segmented into two-
second epochs, yielding 90 possible epochs for each of the EO and EC conditions. 
Artifact detection was 200μV for bad channels and Ocular Artifact Removal (OAR; 
[113]) using a blink slope threshold of 14μV/ms was applied to the EEG data. Eye blink 
and movement threshold was set to 150μV. Spline interpolation was used to replace 
channels with artifacts in more than 40% of trials. EEG data were then re-referenced to 
the average reference of all electrodes and baseline-corrected. Following pre-
processing, there were on average 73 (range: 34-90) EO epochs and 78 (range: 36-90) 
EC epochs (t(48)=-2.03, p=.048). 
Data were exported to Matlab 7.9.0 (R2009b MathWorks, Natick, MA) where Fast 
Fourier Transform analyses were performed. The average spectral power for delta 
(0.5–4Hz) and beta (13–25Hz) frequencies were extracted and natural log transformed 
(ln) given their non-normal distributions. Subsequent statistical analyses were 
performed on the correlation between the ln power of delta and beta frequencies and 
averaged across electrodes sites in: central (C3, C4, Cz), prefrontal (Fp1, Fp2), frontal 
(F3, F4, F7, F8, Fz), parietal (P3, P4, Pz), temporal (T3, T4, T5, T6), and occipital (O1, O2) 
regions (consistent with the 10-20 electrode system; Jasper, 1958; Figure 3D). Ln delta 
and beta power were also compared when averaging across all electrode sites. Although 
spectral data from EO and EC conditions are often averaged together to represent a 
single resting state condition, we compared the ln delta and beta power within and 
between EO and EC conditions given differences that have been reported previously 




Next, Steiger’s [116] modification of Dunn and Clark’s [117] z score was used to test for 
differences between two non-overlapping dependent correlations [118], and 95% 
confidence intervals were calculated [119]. Given the directional hypothesis of 
decreased delta-beta correlations associated with OT, one-tailed tests were employed. 
Effect size is presented as partial eta-squared (η2partial), where .01 represents a small 
effect size, .06 represents a medium effect size, and .14 represents a large effect size 
[120]. Greenhouse-Geisser corrections were used when sphericity assumptions were 
violated. 
ERP Experiment 
For data processing to analyze the ERPs, each EEG file was first digitally filtered with a 
30 Hz low-pass filter for reduction of environmental noise artifacts. The EEG signal was 
subsequently segmented into one-second epochs, beginning 100 ms before and ending 
900 ms after the onset of the stimulus.  Spline interpolation was used to replace 
electrode channels with artifacts in more than 50% of the trials and OAR using a blink 
slope threshold of 14 µV/ms was also applied to all data. 
Electrode clusters as they cover the scalp are presented in Figure 1. Electrodes of 
interest were selected for the N170 using scalp regions characteristically eliciting the 
N170 [121], and conforming to electrode sites used in published dense-array EEG face 
perception studies [50], [122]. These electrode sites consisted of two clusters of six 
electrodes over the left lateral posterior scalp (58 59, 64, 65, 68, and 69) and the right 
lateral posterior scalp (89, 90, 91, 94, 95, and 96). Data for ERP analysis were averaged 
across the six sites in each hemisphere. The N170 time window was derived and 




enabled statistical extraction of each component and ensured they were representative 
of waveform variability. Specifically, the N170 that was extracted for statistical analysis 
was identified and marked as an event at each electrode site per participant. The time 
window ranged across participants from 150 ms to 225 ms, with the N170 peak defined 
as the minimum amplitude falling in that window.  
Figure 1. Electrode array layout with clusters of interest highlighted (top of figure is nasion). N170 
(Circled) = Left hemisphere: 58 59, 64, 65, 68, 69; Right hemisphere: 89, 90, 91, 94, 95, 96. P300/LPP 




For the P300 and the LPP, ERP data were averaged over six electrode sites typically 
used in P300 research (61 62, 67, 72, 77, and 78; [99], [123]) that also overlap with 
published dense-array LPP research [100], [101]. Using time windows of 200 to 400 ms 
and 500 to 800 ms after stimulus onset, we measured the mean amplitudes of the P300 
and the LPP, respectively. Next, the P300 and LPP were both examined in the averaged 
data of each participant to confirm that the component of interest was captured at each 
electrode site. Finally, the mean amplitudes were statistically extracted for each 
participant. 
Statistical analysis was performed using repeated measures of analysis of variance 
(ANOVA). All data were also assessed for their appropriateness for parametric analyses 
and house stimuli were separately analyzed from face stimuli for all components. 
Similar to the EEG Experiment, effect size is presented as η2partial.   
The N170 data for houses were analyzed with a two (spray: OT, placebo) by two 
(hemisphere: left, right) within-subject ANOVA while faces were analyzed using a two 
(spray: OT, placebo) by two (face: infant, adult) by two (emotion: distressed, neutral) by 
two (hemisphere: left, right) within-subject ANOVA. For both the P300 and LPP, a two-
tailed paired t-test was conducted to assess the effect of OT versus placebo 
administration on house stimuli; a two (spray: OT, placebo) by two (face: infant, adult) 
by two (emotion: distressed, neutral) within-subject ANOVA was conducted for face 















































































































































Delta and beta powers 
Scalp topographies for the raw delta and beta powers across each of the experimental 
conditions (EO, EC, EOEC) are presented in Figure 2. The ln power for each electrode, 
resting condition, and spray condition were first separately examined (Table 3) and 
found to have no main effect of spray for either delta [F(1,22)=1.48, p=.24, 
η2partial=.06] or beta [F<1] frequencies. This confirmed that resting delta and beta 
were unaffected by OT administration relative to placebo.  
Table 3. Natural log transformed delta and beta power for each electrode site (including a total 
power averaged across sites) as a function of resting EEG condition (eyes open, eyes closed) and 
spray type (OT, placebo). 
 Electrode Site 
 Prefrontal Frontal Central Parietal Temporal Occipital Total 
Eyes Closed        
Delta-Oxytocin 1.97 1.06 0.50 0.95 0.67 1.01 0.96 
Delta-Placebo 1.88 0.86 0.48 0.81 0.41 0.80 0.80 
Beta-Oxytocin -1.95 -2.64 -2.90 -2.56 -2.74 -1.99 -2.55 
Beta-Placebo -2.07 -2.72 -2.84 -2.54 -2.86 -2.19 -2.61 
Eyes Open        
Delta-Oxytocin 1.57 0.88 0.36 0.71 0.62 0.83 0.78 
Delta-Placebo 1.50 0.65 0.36 0.48 0.37 0.65 0.61 
Beta-Oxytocin -1.68 -2.70 -3.09 -2.92 -2.95 -2.38 -2.71 




There was a main effect of resting EEG condition for both delta [F(1,22)=10.80, p=.003, 
η2partial=.34] and beta [F(1,22)=13.29, p=.001, η2partial=.38], with greater power 
during EC relative to EO. For delta, there was a main effect of electrode site 
[F(3,76)=40.06, p<.001, η2partial=.65], with greater delta in prefrontal and parietal 
regions and lower delta in central regions. These main effects were qualified by resting 
condition and electrode site interaction [F(3,62)=7.52, p<.001, η2partial=.26], showing 
variability in the magnitude of delta during EO and EC conditions (with this difference 
being smallest in temporal electrode sites). There was also a main effect of electrode 
site for beta [F(5,110)=30.85, p<.001, η2partial=.58], with greater power in prefrontal, 
parietal and temporal regions. Similarly, these main effects were qualified by a resting 
condition and electrode site interaction [F(2,40)=36.19, p<.001, η2partial=.62] where 
beta was greater in EO and EC conditions in prefrontal regions but greater in EC than 
EO conditions in other regions.  
There were no other interactions between these variables [F’s<1] for either delta or 
beta. Taken together, these data illustrate how delta and beta vary as a function of the 
resting EEG condition as well as the electrode site where these frequency bands are 
recorded.  Critically, delta and beta powers did not differ as a function of OT or placebo 
administration.  
Cross-frequency coupling  
Delta-beta correlations were next examined between OT and placebo conditions. Figure 
3 depicts delta-beta correlations for EC (Panel A), EO (Panel B), and EOEC averaged 





Figure 3. Delta-beta correlations for placebo and OT conditions at each electrode region (listed on 
the horizontal axis) for the Eyes Closed condition (Panel A), Eyes Open condition (Panel B), and 
Averaged Eyes Open and Closed conditions (Panel C). Schematic of position and naming of electrodes 
using the 10-20 EEG system (Panel D). *Statistical reduction in delta-beta correlation between OT 
and placebo conditions (p<.008; corrected for multiple comparisons); Fp=Prefrontal; F=Frontal; 




In the EC condition, OT administration resulted in decreased delta-beta correlation 
across all electrode sites relative to placebo [z=3.25; p < .01; 95% CI: 0.21–0.99]. 
Examining individual electrode locations separately, delta-beta correlations were 
differentiated by spray condition at prefrontal [z=1.69; p<.05; 95% CI: -0.66–0.88], 
frontal [z=2.14; p<.05; 95% CI: 0.03–0.75], parietal [z=2.80; p<.01; 95% CI: 0.12-0.81], 
temporal [z=2.58; p<.01; 95% CI: 0.10–0.88], and occipital [z=1.71; p<.05; 95% CI: -
0.06–0.80] sites. Central electrode sites did not show a condition difference [z=0.99; 
p=.16; 95% CI: -0.19–0.60]. Notably, after Bonferonni correction for multiple 
comparisons across each site (p<.008), only comparisons between parietal and 
temporal sites remained statistically significant.  
The EO condition had a similar trend for decreased delta-beta correlation after OT 
administration, although no individual electrode site reached statistical significance 
[z’s<1.15; p’s>.12]. After averaging EOEC together as done in prior research, OT 
administration significantly decreased the global delta-beta coupling across all 
electrode sites [z=2.15; p .02; 95% CI: 0.04–0.92]. However, there was no condition 
difference at individual electrode sites or after correcting for multiple conditions (NB: 
parietal [z=2.28; p<.05; 95% CI: 0.05–0.77] and temporal [z=1.69; p<.05; 95% CI: -0.06–
0.82] sites approached statistical significance).  
In summary, intranasal OT administration decreased the resting state EEG delta-beta 








The N170 amplitude for houses showed no main effect of spray (F<1), hemisphere 
[(F(1,23)=2.36, p=.14, η2partial=.04], or their interaction (F<1).  For faces, there was a 
main effect of emotion [F(1,23)=11.38, p=.003, η2partial =.33] and face type 
[F(1,23)=5.11, p=.034, η2partial=.18], but no main effect of spray [F(1,23)=1.06, p=.31, 
η2partial =.04], hemisphere (F<1), or any interactions (p’s >.14). Of note, the mean 
N170 amplitude was attenuated for houses (M=-1.15 mV; SD=1.34) compared with all 
face types, regardless of expression (Infant M=-3.46 mV, SD 2.40; Adult M=-3.27 mV, SD 
2.13).  
 
Figure 4. Mean P300 amplitudes for adult and infant face stimuli after placebo and OT 
administration. * Mixed effects within subject ANOVA showed main effect of face (p=.03) and Face x 






A paired t-test comparing mean P300 amplitude for houses after placebo or OT showed 
no significant difference [t(23)=-1.41, p=.17]. For face stimuli, the P300 amplitude was 
modulated by face type [F(1,23)=5.21, p=.03, η2partial=.19], which was qualified by a 
face x spray interaction, [F(1,23)=5.20, p=.03, η2partial=.18]. There was no main effect 
of spray [F(1,23)=1.75, p=.20, η2partial =.07] or emotion (F<1). Figure 4 shows the 
mean P300 amplitude for each face type and spray condition, depicting how OT 
administration selectively led to an increased P300 for infant faces compared with adult 
faces. 
LPP 
A paired t-test comparing mean LPP amplitudes for houses showed no significant 
difference between the placebo and OT conditions [t(22)=1.12, p=.27]. There were also 






Despite the large number of social cognition and behavioral studies that have employed 
intranasal OT administration, the neural mechanisms modulated by this neuropeptide 
remains elusive and not well understood. In this present study, the influence of 
intranasal OT was assessed using electroencephalography in a group of healthy, 
nulliparous women. We examined how OT compared with placebo influenced the 
resting state EEG correlations between delta and beta frequency bands, and affected 
ERP responses to social and nonsocial stimuli.  
During resting state EEG recording, while OT did not modulate the amplitudes of delta 
and beta oscillations individually, it did decrease the cross-frequency coupling of delta 
and beta across EEG scalp sites. Exploring ERP data, OT administration led to increased 
P300 amplitude in response to infant faces as compared to adult faces, without affecting 
N170 or LPP amplitudes. Taken together, these findings suggest that a potential 
mechanism through which to understand how OT administration modulates attention 
allocation for infant cues may be by studying the interrelationships between neural 
oscillations; delta-beta represents one such relationship but other oscillations should be 
examined as well. 
Neural Responses to Oxytocin 
To our knowledge, this is the first study to explore how OT administration affects the 
correlation between spectral powers. Accumulating research is focusing on 
understanding neural network functions through the interactions between fast and 




generators, respectively [87]. Indeed, previous research on cross-frequency coupling 
have been conducted using cortisol [89] and testosterone [124]; those researchers 
similarly observed hormone modulation of cross-frequency coupling without any effect 
on individual resting delta and beta frequencies. These findings suggest that the 
observed changes in delta-beta correlation may not be due to general neural activity or 
arousal changes from the hormone administration, but rather reflect spectral coherence 
changes in the underlying neurobiological systems.  
As low-frequency oscillations like delta waves are physiologically thought to arise from 
subcortical regions while high-frequency oscillations like beta waves are hypothesized 
to originate in cortical circuits, the apparent changes in delta-beta correlation may 
represent shifts in subcortical-cortical interactions [85]. To date, a majority of research 
describes increased delta-beta coupling as associated with anxiogenic contexts and 
emotional dysregulation [87], which converges well with OT’s anxiogenic properties 
[125]. Interestingly, a few studies suggest that alterations in this coupling are driven by 
and are more sensitive to changes in delta activity than beta [87], [88], implying greater 
subcortical influences on this relationship. Since slow waves are thought to be involved 
in the discrimination of emotional stimuli [126], perhaps changes in delta-beta coupling 
reflect changes in emotional salience. One subcortical brain structure that is strongly 
involved with emotion—and anxiety—is the amygdala. Converging with this, OT 
administration has been shown to alter the functional connectivity between the 
amygdala and the bilateral insula and medial and dorsal anterior cingulate cortices in 




An advantage of using dense-array EEG methodology is the scalp coverage it provides 
despite poor spatial resolution beyond the cortical surface. We found that decreased 
delta-beta coupling was more pronounced in the temporal and parietal regions, which 
corresponds with fMRI data suggesting that OT effects are the most strongly influenced 
and produced the largest effect sizes across research studies in the temporal lobes [38]. 
These findings correspond with research implicating the temporal regions in the 
processing of emotional cues [128]–[131] and the parietal regions in attentional 
processing [132], [133]. Furthermore, delta-beta coupling has been suggested to be a 
neural correlate of attentional avoidance of threat [134]. Thus, one interpretation of 
decreased coupling in temporal and parietal lobes with OT administration may be that 
the anxiolytic effects of OT dampen attentional processing of affective stimuli through 
modulation of these neural networks.  
A strength of the current study is the examination of neural oscillations at multiple 
electrode sites, separately and together, for the different resting conditions. We notably 
found that although modulation of delta-beta coupling by OT was present when data 
from the eyes-closed and eyes-opened recording periods were averaged together as is 
typically done in EEG research, it was most prominent in the eyes-closed resting 
condition. The physiology behind this phenomenon is not clearly understood, although 
studies have shown that there is increased spontaneous activity [115] and generalized 
low frequency power increase [114] during EC conditions which may render the 
oscillation changes to be more easily visualized. Regardless, it may be valuable to 
consider these conditions separately as well as together in future research. Indeed, 




coupling at trend-level significance during the eyes-open condition across the scalp, 
which may reflect a need for a larger sample size to better elicit this phenomenon. 
Oxytocin and Infant Cues 
Through capitalizing on the temporal strength of ERPs, we learned how OT may affect 
different stages of stimulus processing—from perception and the N170 to attention and 
cognition with the P300 and LPP. In our cohort of healthy nulliparous women, the N170 
was expectedly attenuated for house compared to face stimuli, and enhanced for infant 
faces and distressed expressions compared to adult faces and neutral expressions, 
respectively. This is consistent with prior studies showing increased N170 amplitude 
with infant faces, particularly those that are distressed [68], [93], [94]. Modulation of 
the N170 by face type and emotion is in line with the component’s association with low-
level categorization of visual stimuli, and suggests the importance of efficient 
processing of infant faces and the discrimination of distress.  
On the other hand, neither the P300 nor the LPP were modulated by emotional 
expression. OT administration increased the amplitude of only the P300 component 
after participants viewed infant faces compared with adult faces, and did not affect the 
amplitudes of the N170 or LPP as was originally hypothesized. Such an outcome implies 
that OT mainly affects the temporally later stages of stimulus processing without 
changing the initial perceptual processing of the faces themselves. The increased 
amplitude of the P300 demonstrates that OT administration was associated with 
participants allocating greater attentional resources to infant faces than adult faces. OT 
consequently selectively rendered infant faces more salient and relevant, which is 




infant cues [45] and in the enhancement of the P300 when participants evaluate stimuli 
of greater motivational importance [97].  
Whereas our results of OT’s effect on resting delta-beta coupling suggested anxiolysis 
through a dampening of baseline attentional processes, its effect on the P300 
conversely suggested increased attentional allocation to infant stimuli. These seemingly 
inconsistent results may be due to resting-state EEG oscillations inherently measuring 
different aspects of neuronal processing than ERPs, or can be resolved through the 
perspective that OT renders infant cues to be both more salient and less anxiety-
provoking. Further taking into consideration that OT had the greatest impact on delta-
beta correlation in the parietal and temporal lobes, multiple ERP and fMRI studies have 
inferred the generation of the P300 to be from an interaction between the frontal and 
the temporal-parietal lobes [96], [135]. New research has also shown OT’s ability in 
altering the balance of inhibitory and excitatory neurons projecting from the 
hypothalamus to the cortex; these connections appear to directly control the 
development in virgin mice of a behavioral response to crying pups and subsequent 
memory formation for the socially relevant sounds [136]. Altogether, our data supports 
a role for OT in modulating neuronal circuitry from subcortical to neocortical regions, 
and selectively strengthening resource and attentional allocation to neural processes 
that are involved in handling infant cues, while potentially making these cues less 
aversive. 
The lack of either face, emotion, or OT effect on the LPP was surprising, given its 
intimate relationship functionally and electrophysiologically with the P300. Our results 




in female undergraduates to emotional faces [100]. However, this published study was 
predominantly driven by participants reporting lower maternal love withdrawal, and 
was affected by oral contraceptive use. The authors suggested that participants with 
higher love withdrawal may have maximum facial or emotional processing even under 
placebo administration and would not gain the benefit of additional OT [100]. This is 
consistent with other research connecting early childhood experiences with OT 
sensitivity [15], and may explain why we did not observe an effect without elucidating 
and analyzing our participants based on these personal characteristics. Since the LPP 
represents a conscious allocation of attention compared to the P300 [97], individual 
traits may play a greater role in impacting this component and would be a direction of 
future research. Consistent with this idea is a recently published study showing 
enhanced LPP in a cohort of mothers shown distressed compared to neutral infant faces  
[101], which together with our lack of LPP effect by infant faces in a nulliparous group, 
further provides support for a uniquely maternal brain.  
Along the same vein, although infant faces elicited stronger N170 amplitudes than adult 
faces in our cohort of nulliparous women, OT did not modulate this difference. The 
N170 has been shown to be greater in response to infant cues in parents and individuals 
in romantic relationships than in individuals who are single or have no children [93], 
[137]. Although all our participants have never been pregnant, we did not ask for 
relationship status or caregiving experiences which may both play modulating roles. 
However, it may be that low-level perceptual or visual processing (represented by the 
N170) are simply not affected by OT [138]. In fact, there is some data showing that the 




infant to the mother [99].  As such, OT administration may not change early neural 
responses to an already salient infant cue.  
Limitations and Future Directions 
An important limitation to many intranasal OT studies is small sample sizes leading to 
underpowered results and low positive predictive values [139].  We strived to offset 
this limitation through stringent inclusion and exclusion criteria and a within-
participant experimental design. However, the generalizability of these results to male 
participants needs to be established, and future studies using mixed male and female 
samples could directly enable between-gender comparisons as well as a replication of 
our findings among other female subjects. Moreover, the importance of individual 
differences on OT’s influence requires the need for establishing how varying socio-
emotional and personality traits, as well as physiological or pathological states such as 
pregnancy or depression, may contribute to its effects (e.g. [140]). Further analysis is 
ongoing to examine any interactions between the self-report questionnaires (regarding 
anxiety, depression, stress, and early bonding experiences) completed by our 
participants and the neuro-electrophysiological data; these results will be explored in a 
separate manuscript. 
While we found that OT administration did not affect resting delta or beta oscillatory 
power, exploring other frequency bands may be worthwhile. Furthermore, although the 
difference between relative and absolute power measures is beyond the scope of this 
thesis, it is important to note that these measured oscillations of individual frequency 
bands represent proportions of multiple frequencies in a recorded EEG, all of which 




on delta-beta correlations due to prior research identifying their role in modulating 
stress- and anxiety-associated contexts, as well as in interfacing with emotion and 
cognition [85], [89], [90], [124]. Indeed, some studies have shown intranasal OT leading 
to greater low alpha / mu (8-10Hz) and beta suppression during the viewing of 
biological motion [141]. Thus, exploration of OT effects within, as well as across, other 
frequency bands and experimental paradigms may be warranted. It is also worth noting 
that the analyses we report assumed a linear correlation between the amplitudes of 
these oscillations, while other studies have suggested distal brain regions may have 
non-linear relationships representing different sets of brain dynamics and functions 
[142]. We also only examined amplitude-amplitude synchrony between delta and beta, 
in contrast to phase-phase or phase-amplitude measures [143] which can elucidate 
other important mechanistic associations of cognitive function (reviewed in [142]). 
In regards to the event-related potentials, our results could be further informed by 
including faces with positive expressions to compare neural responses to negative and 
neutral faces. Since identity and emotional processing of faces are intimately 
interlocked [102], we may expect similar results irrespective of emotional valence. 
However, multiple studies suggest that infant happiness or distress as represented by 
facial expression and cries may activate very different brain regions in parents and non-
parents [61], [68], [70]. There is also is a dearth of studies assessing the span of basic 
emotions since studies have primarily focused on happy and angry as representation 
for positive and negative expressions [25]. For the P300 in particular, we focused on its 
amplitude as a whole, instead of separately analyzing its individual temporal 




mechanisms arising from different brain loci [96] and may be differentially affected by 
both facial or emotional category and OT administration. 
Finally, although EEG arises from neurotransmission and neural activity, it is ultimately 
a correlational technique; the precise anatomic origins of our results are not known and 
require additional neuroimaging studies aimed towards determining neuroanatomical 
and neurophysiological correlates. It is also possible that the commonly used dosage of 
24IU intranasal OT is insufficient for delivering an effective cerebral concentration. This 
can either, or both, mask any true neurological effects or lead to inaccurate 
apportionment of peripherally driven OT effects to central OT activity [22], [139]. The 
latter situation is less likely for this thesis given our direct neural measurements using 
EEG, but it would be beneficial to conduct dose-response studies and examine whether 
these neural relationships are functions of OT levels. Through using varying OT dosages 
and measuring saliva OT levels at different experimental time points, we can more 
effectively link dynamic hormonal changes with social or electrophysiological behavior. 
Conclusion  
In summary, the present study explored how intranasal OT administration affected the 
neural oscillations and responses to infant faces in a cohort of healthy, nulliparous 
women. We demonstrated that OT decreased delta-beta coupling in the resting brain 
and increased the amplitude of the P300 as elicited by infant faces compared with adult 
faces. This provides a potential mechanism through which intranasal OT may modulate 
brain and social behavior on a neural level, and supports the value of EEG in examining 
the integration of dynamically changing cortical and subcortical neural networks. By 




interactions that OT modulates between subcortical and cortical brain regions, while 
the use of ERP further provided us the ability to identify the processing stage at which 
OT influences the handling of affiliative stimuli. Overall, this thesis adds to the 
intranasal OT literature a potential tool for measuring OT action with delta-beta 
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